185 related articles for article (PubMed ID: 28902848)
1. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
Keating SM; Dodge JL; Norris PJ; Heitman J; Gange SJ; French AL; Glesby MJ; Edlin BR; Latham PS; Villacres MC; Greenblatt RM; Peters MG;
PLoS One; 2017; 12(9):e0181004. PubMed ID: 28902848
[TBL] [Abstract][Full Text] [Related]
2. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
[TBL] [Abstract][Full Text] [Related]
4. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
5. HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.
Lamoury FM; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J;
BMC Infect Dis; 2016 Jun; 16():241. PubMed ID: 27246604
[TBL] [Abstract][Full Text] [Related]
6. Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.
Hajarizadeh B; Lamoury FM; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J; Applegate TL;
Virol J; 2016 Feb; 13():32. PubMed ID: 26911712
[TBL] [Abstract][Full Text] [Related]
7. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
Valcour VG; Rubin LH; Obasi MU; Maki PM; Peters MG; Levin S; Crystal HA; Young MA; Mack WJ; Cohen MH; Pierce CB; Adimora AA; Tien PC;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):266-73. PubMed ID: 26885801
[TBL] [Abstract][Full Text] [Related]
8. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.
Reiberger T; Aberle JH; Kundi M; Kohrgruber N; Rieger A; Gangl A; Holzmann H; Peck-Radosavljevic M
Antivir Ther; 2008; 13(8):969-76. PubMed ID: 19195322
[TBL] [Abstract][Full Text] [Related]
9. Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.
Chen X; Liu X; Duan S; Tang R; Zhou S; Ye R; Yang Y; Wang J; Yao S; He N
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348839
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.
Anadol E; Schierwagen R; Elfimova N; Tack K; Schwarze-Zander C; Eischeid H; Noetel A; Boesecke C; Jansen C; Dold L; Wasmuth JC; Strassburg CP; Spengler U; Rockstroh JK; Odenthal M; Trebicka J
Hepatology; 2015 Jan; 61(1):46-55. PubMed ID: 25125218
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
[TBL] [Abstract][Full Text] [Related]
13. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
Abad-Fernández M; Moreno A; Dronda F; del Campo S; Quereda C; Casado JL; Pérez-Elías MJ; Moreno S; Vallejo A
AIDS; 2015 Feb; 29(4):401-9. PubMed ID: 25565497
[TBL] [Abstract][Full Text] [Related]
14. [ANRS-fibrovic and homavic: role of non invasive markers of liver fibrosis and insulin resistance during antiviral treatment in HIV-HCV co-infected patients from ANRS HC 02 RIVABIC trial].
Halfon P; Pénaranda G; Cacoub P
Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S113-7. PubMed ID: 19375039
[TBL] [Abstract][Full Text] [Related]
15. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.
Berenguer J; Fernandez-Rodríguez A; Jimenez-Sousa MA; Cosín J; Zarate P; Micheloud D; López JC; Miralles P; Catalán P; Resino S
Cytokine; 2012 Jan; 57(1):25-9. PubMed ID: 22136974
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Reiberger T; Payer BA; Ferlitsch A; Sieghart W; Breitenecker F; Aichelburg MC; Schmied B; Rieger A; Trauner M; Peck-Radosavljevic M;
Antivir Ther; 2012; 17(7):1327-34. PubMed ID: 22948263
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.
Armah KA; Quinn EK; Cheng DM; Tracy RP; Baker JV; Samet JH; Freiberg MS
BMC Infect Dis; 2013 Aug; 13():399. PubMed ID: 23987993
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.
Dai CY; Ho CK; Huang JF; Hsieh MY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML; Chuang WL
J Hepatol; 2010 Feb; 52(2):160-6. PubMed ID: 20034694
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects.
Hu S; Ghabril M; Amet T; Hu N; Byrd D; Yang K; Vuppalanchi R; Saxena R; Desai M; Lan J; Johnson R; Gupta S; Chalasani N; Yu Q
PLoS One; 2014; 9(2):e86964. PubMed ID: 24516541
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
Roe B; Coughlan S; Hassan J; Grogan A; Farrell G; Norris S; Bergin C; Hall WW
J Infect Dis; 2007 Oct; 196(7):1053-7. PubMed ID: 17763328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
